Transfusion practices for patients with sickle cell disease at a major academic medical center

1.National Institutes of Health, National Heart, Lung, and Blood Institute. Management of sickle cell disease. 4th ed. Washington, DC: National Institutes of Health; 2002. NIH publication 02-2117. http://www.nhlbi.nih.gov/health/prof/blood/ sickle/sc_mngt.pdf.Search in Google Scholar

2.Adams, RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann of Neurol 1997;42:699-704.10.1002/ana.4104205059392568Search in Google Scholar

3.Adams, RJ, McKie VC, Hsu L, et al. Prevention of first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339:5-11.10.1056/NEJM1998070233901029647873Search in Google Scholar

4.Adams RJ, Brambilla D; for the optimizing primary stroke prevention in sickle cell anemia (STOP 2) trial investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005; 353:2769-78.10.1056/NEJMoa05046016382063Search in Google Scholar

5.Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin in Hematol 2001;38(Suppl 1):5-13.10.1053/shem.2001.2013911206961Search in Google Scholar

6.Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.10.1056/NEJM1990060732223012342522Search in Google Scholar

7.Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990;76:1431-7.10.1182/blood.V76.7.1431.1431Search in Google Scholar

8.Orlina A, Sosler SD, Koshy M. Problems of chronic transfusion in sickle cell disease. J Clin Apher 1991;6:234-240.10.1002/jca.29200604131816246Search in Google Scholar

9.Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94-8.10.1046/j.1537-2995.1987.27187121485.x3810834Search in Google Scholar

10.Afenyi-Annan A, Lottenberg R, Konrad TR. Blood bank practices for sickle cell patients in North Carolina (abstract). Transfusion 2004;44(Suppl 9):135.10.1111/j.1537-2995.2004.00369.x15043582Search in Google Scholar

11.Afenyi-Annan A, Brecher M. Pre-transfusion phenotype matching for sickle cell patients (letter). Transfusion 2004;44:619-20.10.1111/j.1537-2995.2004.00369.xSearch in Google Scholar

12.Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Vox Sang 1992;63:186-91.10.1111/j.1423-0410.1992.tb05098.x1448963Search in Google Scholar

13.American Red Cross.“CIAA Increase Minority Blood and Bone Marrow Donations.” Available at: http://www.redcross.org/article/0,1072,0_332_23 17,00.html. Accessed March 5, 2004.Search in Google Scholar

14.Afenyi-Annan A, Parrish T. African American blood donors at a local historically black college/ university (abstract). Transfusion 2004;44(Suppl 9):183-18.10.1111/j.1537-2995.2004.00369.x15043582Search in Google Scholar